查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲数位 PCR 市场按应用、最终用户和国家划分 - 分析和预测（2024-2034 年）
市场调查报告书
商品编码
1681515

欧洲数位 PCR 市场按应用、最终用户和国家划分 - 分析和预测（2024-2034 年）

Europe Digital PCR Market: Focus on Application, End User, and Country Analysis - Analysis and Forecast, 2024-2034
出版日期: | 出版商: BIS Research | 英文 72 Pages | 商品交期: 1-5个工作天内

价格

欧洲数位 PCR (d-PCR) 市场规模预计将从 2024 年的 1.839 亿美元成长到 2034 年的 7.627 亿美元，2024-2034 年预测期内的复合年增长率为 15.29%。

由于个人化医疗在筛检和诊断遗传疾病方面的应用越来越多，欧洲数位 PCR 市场正在经历两位数的成长。这种针对患者的个人化策略在很大程度上依赖数位 PCR（dPCR）来准确识别和测量与各种癌症相关的罕见基因突变。此外，欧洲各地感染疾病的不断上升也推动了对快速且准确的诊断解决方案的需求。欧洲市场的成长极大地促进了液滴数位 PCR、奈米板技术和微流体平台等技术进步，这些技术进步提高了 dPCR 的功能。

主要市场统计数据
预测期 2024-2034
2024 年评估 1.839亿美元
2034 年预测 7.627亿美元
复合年增长率 15.29％

由于个人化医疗的普及和对极其精准的诊断的需求，数位 PCR 市场在欧洲正在快速成长。数位 PCR (dPCR) 具有出色的敏感性和特异性，特别适用于识别低丰度遗传变异以及测量早期诊断和治疗监测至关重要的生物标记。感染疾病、遗传疾病和癌症的增加促使人们对尖端分子诊断技术的投资。

液滴数位 PCR、奈米板技术和微流体平台等技术进步正在显着提高检测精度、通量和整合到临床工作流程的简易性。此外，由于政府倡议、有利的法律规范以及对医疗保健基础设施的资金增加，整个非洲大陆的市场采用正在加速。随着顶尖研究机构和商业领袖不断联手打造可靠的、特异性患者的诊断解决方案，欧洲数位 PCR 市场预计将稳定成长。除了改变分子诊断的模式之外，这个充满活力的市场也为改善患者治疗效果的个人化治疗方案打开了大门。

总体而言，技术创新、监管支援和不断发展的临床需求共同推动欧洲数位 PCR 市场的强劲扩张。此外，预计不断增长的研究合作和投资将进一步促进数位 PCR 在欧洲的融合。

本报告研究了欧洲数位 PCR 市场，并提供了市场概述、按应用、最终用户和国家分類的趋势以及参与市场的公司概况。

目录

执行摘要

第一章 市场

  • 市场概况
  • 趋势：当前和未来的影响评估
  • 供应链概览
  • 研发回顾
  • 正在进行的数位 PCR 临床试验
  • 监管状态
  • 市场动态概览

第二章 区域

  • 区域摘要
  • 驱动因素与限制因素
  • 欧洲

第三章市场-竞争基准化分析与公司概况

  • 竞争格局
  • 市场占有率分析
  • 公司简介
    • QIAGEN NV
    • F. Hoffmann-La Roche Ltd
    • Merck KGaA
    • Stilla Technologies Inc.
    • SAGA Diagnostics AB
    • JETA Molecular BV.

第四章调查方法

Product Code: BHP2684SS

Introduction to Europe Digital PCR Market

The Europe digital PCR (d-PCR) market is projected to reach $762.7 million by 2034 from $183.9 million in 2024, growing at a CAGR of 15.29% during the forecast period 2024-2034. The market for digital PCRs in Europe has grown by double digits due to the increasing use of personalised medicine for genetic disorder screening and diagnosis. This patient-specific strategy relies heavily on digital PCR (dPCR), which accurately identifies and measures uncommon genetic mutations connected to a range of cancers. Furthermore, the need for quick and precise diagnostic solutions is being fuelled by the growing incidence of infectious diseases throughout Europe. The market's growth in Europe is being greatly aided by technological advancements like droplet digital PCR, nanoplate technology, and microfluidic platforms, which are improving dPCR capabilities.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2034
2024 Evaluation$183.9 Million
2034 Forecast$762.7 Million
CAGR15.29%

The market for digital PCR is growing quickly in Europe due to the growing use of personalised medicine and the need for extremely accurate diagnostics. With its remarkable sensitivity and specificity, digital PCR (dPCR) is especially useful for identifying low-abundance genetic mutations and measuring biomarkers that are essential for early diagnosis and treatment monitoring. Increasing rates of infectious diseases, genetic disorders, and cancers have prompted investments in cutting-edge molecular diagnostic technologies.

The accuracy, throughput, and ease of integration of assays into clinical workflows have been greatly enhanced by technological advancements like droplet digital PCR, nanoplate technology, and microfluidic platforms. Furthermore, market adoption has accelerated throughout the continent due to government initiatives, favourable regulatory frameworks, and increased funding for healthcare infrastructure. The European digital PCR market is expected to grow steadily as top research institutes and business leaders keep working together to create reliable, patient-specific diagnostic solutions. In addition to changing the molecular diagnostics landscape, this dynamic market is opening the door for individualised treatment plans that improve patient outcomes.

Overall, the convergence of technological innovation, regulatory support, and evolving clinical demands is driving the digital PCR market's robust expansion in Europe. Additionally, growing research collaborations and investments will further integrate digital PCR in Europe.

Market Segmentation:

Segmentation 1: by Application

  • Clinical and Research Application
  • Environmental Application
  • Other Application

Segmentation 2: by End User

  • Academic and Research Institutes
  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharmaceutical and Biopharmaceutical Companies
  • Other End User

Segmentation 3: by Region

  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe digital PCR market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Mergers, acquisitions, and product launches accounted for the maximum number of key developments.

Competitive Strategy: The Europe digital PCR market has numerous established players with product portfolios. Key players in the Europe digital PCR market analyzed and profiled in the study involve established players offering products for digital PCR.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Stilla Technologies Inc.
  • SAGA Diagnostics AB
  • JETA Molecular BV.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Market Overview
    • 1.1.1 Workflow of Digital PCR
    • 1.1.2 Comparison of qPCR and dPCR
  • 1.2 Trends: Current and Future Impact Assessment
    • 1.2.1 Integration with Next-Generation Sequencing (NGS)
    • 1.2.2 Increased Real-time Monitoring and Point-of-care Applications of Digital PCR
    • 1.2.3 Increasing Product Launches in d-PCR Ecosystem
  • 1.3 Supply Chain Overview
  • 1.4 Research and Development Review
    • 1.4.1 Patent Filing Trend (by Region)
    • 1.4.2 Patent Filing Trend (by Country)
    • 1.4.3 Patent Filing Trend (by Year)
  • 1.5 Ongoing Digital PCR Clinical Trials
  • 1.6 Regulatory Landscape
    • 1.6.1 European Union
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
      • 1.7.1.1 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
      • 1.7.1.2 Increasing Incidence of Infectious Diseases
      • 1.7.1.3 Technological Advancement in dPCR to Enhance Market Growth
    • 1.7.2 Market Restraints
      • 1.7.2.1 High Cost of Platforms Associated with Digital-PCR
      • 1.7.2.2 Shortage of Skilled Professionals and Trained Laboratory Technicians
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
      • 1.7.3.2 Growing Adoption of dPCR in Emerging Markets

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 By Application
    • 2.3.5 By End User
    • 2.3.6 France
    • 2.3.7 Germany
    • 2.3.8 U.K.
    • 2.3.9 Spain
    • 2.3.10 Italy
    • 2.3.11 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Landscape
    • 3.1.1 Mergers and Acquisitions
    • 3.1.2 Synergistic Activities
    • 3.1.3 Product Launch and Approval Activities
    • 3.1.4 Expansion, Funding, and Other Activities
  • 3.2 Market Share Analysis
  • 3.3 Company Profile
    • 3.3.1 QIAGEN N.V.
      • 3.3.1.1 Overview
      • 3.3.1.2 Top Products/Product Portfolio
      • 3.3.1.3 Top Competitors
      • 3.3.1.4 Target Customers
      • 3.3.1.5 Key Personnel
      • 3.3.1.6 Analyst View
    • 3.3.2 F. Hoffmann-La Roche Ltd
      • 3.3.2.1 Overview
      • 3.3.2.2 Top Products/Product Portfolio
      • 3.3.2.3 Top Competitors
      • 3.3.2.4 Target Customers
      • 3.3.2.5 Key Personnel
      • 3.3.2.6 Analyst View
    • 3.3.3 Merck KGaA
      • 3.3.3.1 Overview
      • 3.3.3.2 Top Products/Product Portfolio
      • 3.3.3.3 Top Competitors
      • 3.3.3.4 Target Customers
      • 3.3.3.5 Key Personnel
      • 3.3.3.6 Analyst View
    • 3.3.4 Stilla Technologies Inc.
      • 3.3.4.1 Overview
      • 3.3.4.2 Top Products/Product Portfolio
      • 3.3.4.3 Top Competitors
      • 3.3.4.4 Target Customers
      • 3.3.4.5 Key Personnel
      • 3.3.4.6 Analyst View
    • 3.3.5 SAGA Diagnostics AB
      • 3.3.5.1 Overview
      • 3.3.5.2 Top Products/Product Portfolio
      • 3.3.5.3 Top Competitors
      • 3.3.5.4 Target Customers
      • 3.3.5.5 Key Personnel
      • 3.3.5.6 Analyst View
    • 3.3.6 JETA Molecular BV.
      • 3.3.6.1 Overview
      • 3.3.6.2 Top Products/Product Portfolio
      • 3.3.6.3 Top Competitors
      • 3.3.6.4 Target Customers
      • 3.3.6.5 Key Personnel
      • 3.3.6.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Digital PCR Market, by Region, $Million, 2023, 2029, and 2034
  • Figure 2: Europe Digital PCR Market (by Application), $Million 202, 2029 and 2034
  • Figure 3: Europe Digital PCR Market (by End User), $Million, 2023, 2029, and 2034
  • Figure 4: Key Events to Keep Track of in the Digital PCR Market
  • Figure 5: Supply Chain and Risks within the Supply Chain
  • Figure 6: Digital PCR Market (by Region), January 2020-September 2024
  • Figure 7: Digital PCR Market (by Country), January 2020-September 2024
  • Figure 8: Digital PCR Market (by Year), January 2020-September 2024
  • Figure 9: Impact Analysis of Market Navigating Factors, 2024-2034
  • Figure 10: France Digital PCR Market, $Million, 2023-2034
  • Figure 11: Germany Digital PCR Market, $Million, 2023-2034
  • Figure 12: U.K. Digital PCR Market, $Million, 2023-2034
  • Figure 13: Spain Digital PCR Market, $Million, 2023-2034
  • Figure 14: Italy Digital PCR Market, $Million, 2023-2034
  • Figure 15: Rest-of-Europe Digital PCR Market, $Million, 2023-2034
  • Figure 16: Strategic Initiatives, January 2019-September 2024
  • Figure 17: Share of Strategic Initiatives, January 2019-September 2024
  • Figure 18: Digital PCR Market, Mergers and Acquisitions, January 2019-September 2024
  • Figure 19: Digital PCR Market, Synergistic Activities, January 2019-September 2024
  • Figure 20: Digital PCR Market, Product Launch and Approval Activities, January 2019-September 2024
  • Figure 21: Digital PCR Market, Expansion, Funding, and Other Activities January 2019-September 2024
  • Figure 22: Data Triangulation
  • Figure 23: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 24: Top-Down Approach (Segment-Wise Analysis)
  • Figure 25: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Digital PCR Market, Share Analysis, 2023
  • Table 4: Comparison of qPCR and dPCR
  • Table 5: Digital PCR Market, Trend Analysis
  • Table 6: Digital PCR Market, Recent Product Launches
  • Table 7: Some of the Ongoing Digital PCR (d-PCR) Clinical Trials
  • Table 8: Funding Allocated for Precision Medicine to Different Agencies Globally
  • Table 9: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
  • Table 10: Digital PCR Market (by Region), $Million, 2023-2034
  • Table 11: Europe Digital PCR Market (by Application), $Million, 2023-2034
  • Table 12: Europe Digital PCR Market (by End User), $Million, 2023-2034
  • Table 13: France Digital PCR Market (by Application), $Million, 2023-2034
  • Table 14: France Digital PCR Market (by End User), $Million, 2023-2034
  • Table 15: Germany Digital PCR Market (by Application), $Million, 2023-2034
  • Table 16: Germany Digital PCR Market (by End User), $Million, 2023-2034
  • Table 17: U.K. Digital PCR Market (by Application), $Million, 2023-2034
  • Table 18: U.K. Digital PCR Market (by End User), $Million, 2023-2034
  • Table 19: Spain Digital PCR Market (by Application), $Million, 2023-2034
  • Table 20: Spain Digital PCR Market (by End User), $Million, 2023-2034
  • Table 21: Italy Digital PCR Market (by Application), $Million, 2023-2034
  • Table 22: Italy Digital PCR Market (by End User), $Million, 2023-2034
  • Table 23: Rest-of-Europe Digital PCR Market (by Application), $Million, 2023-2034
  • Table 24: Rest-of-Europe Digital PCR Market (by End User), $Million, 2023-2034
  • Table 25: Digital PCR Market. Market Share Analysis, 2023